Features, Treatment, and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus

Arthritis and Rheumatology

Volumn 70, Issue 4, 2018, Pages 616-624

  Borgia, R Ezequiel ^a   Gerstein, Maya ^a   Levy, Deborah M ^a   Silverman, Earl D ^a   Hiraki, Linda T ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANAKINRA; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; ETOPOSIDE; FERRITIN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; PREDNISONE; RITUXIMAB; STEROID; CORTICOSTEROID;

ADOLESCENT; ARTICLE; BACTEREMIA; CANDIDA; CENTRAL NERVOUS SYSTEM DISEASE; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL OUTCOME; COHORT ANALYSIS; COMA; CONCURRENT INFECTION; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; DRUG MEGADOSE; EPSTEIN BARR VIRUS INFECTION; ERYTHROPHAGOCYTOSIS; ESCHERICHIA COLI; FEMALE; FEVER; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED LYMPHADENOPATHY; HEMIPARESIS; HOSPITAL ADMISSION; HUMAN; HUMAN ALPHAHERPESVIRUS 1; HUMAN TISSUE; INCIDENCE; KIDNEY DISEASE; KIKUCHI DISEASE; LABORATORY; LOW DRUG DOSE; LUPUS VULGARIS; LYMPHADENOPATHY; LYMPHOCYTOPENIA; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MORTALITY; MORTALITY RATE; PANCYTOPENIA; PEDIATRIC INTENSIVE CARE UNIT; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; SEIZURE; SKIN INFECTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; URINARY TRACT INFECTION; VISUAL HALLUCINATION; CHILD; HOSPITALIZATION; IMMUNOLOGY; KAPLAN MEIER METHOD; ONSET AGE; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADRENAL CORTEX HORMONES; AGE OF ONSET; CHILD; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; KAPLAN-MEIER ESTIMATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGE ACTIVATION SYNDROME; MALE; PROSPECTIVE STUDIES;

EID: 85042660397     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.40417     Document Type: Article

References (31)

1. Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C, et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine (Baltimore) 2006;85:169–82.
2. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 2004;3:69–75.
3. Parodi A, Davì S, Pringe AB, Pistorio A, Ruperto N, Magni-Manzoni S, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009;60:3388–99.
4. Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol 2010;22:561–6.
5. Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet 2014;383:1503–16.
6. Silverman ED, Miller JJ III, Bernstein B, Shafai T. Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis. J Pediatr 1983;103:872–6.
7. Kumakura S, Murakawa Y. Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol 2014;66:2297–307.
8. Bennett TD, Fluchel M, Hersh AO, Hayward KN, Hersh AL, Brogan TV, et al. Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum 2012;64:4135–42.
9. Gormezano NW, Otsuzi CI, Barros DL, da Silva MA, Pereira RM, Campos LM, et al. Macrophage activation syndrome: a severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients. Semin Arthritis Rheum 2016;45:706–10.
10. Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, Yang YH, et al. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol 2012;31:1223–30.
11. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders: a retrospective study of 24 patients. Rheumatology (Oxford) 2001;40:1285–92.
12. Stabile A, Bertoni B, Ansuini V, La Torraca I, Salli A, Rigante D. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age. Eur Rev Med Pharmacol Sci 2006;10:53–9.
13. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421–6.
14. Pringe A, Trail L, Ruperto N, Buoncompagni A, Loy A, Breda L, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus 2007;16:587–92.
15. Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677–86.
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
17. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124–31.
18. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599–608.
19. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999;286:1957–9.
20. Zhang K, Filipovich AH, Johnson J, Marsh RA, Villanueva J. Hemophagocytic lymphohistiocytosis, familial. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJ, Stephens K, et al, editors. GeneReviews. Seattle (WA): University of Washington, Seattle; 1993–2018.
21. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al, on behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited [published erratum appears in J Am Soc Nephrol 2004;15:835–6]. J Am Soc Nephrol 2004;15:241–50.
22. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002;46:436–44.
23. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363–9.
24. Wong KF, Hui PK, Chan JK, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med 1991;114:387–90.
25. Sakurai T, Kono I, Kabashima T, Yamane K, Nagasawa T, Kashiwagi H. Amegakaryocytic thrombocytopenia associated with systemic lupus erythematosus successfully treated by a high-dose prednisolone therapy. Jpn J Med 1984;23:135–8.
26. Atteritano M, David A, Bagnato G, Beninati C, Frisina A, Iaria C, et al. Haemophagocytic syndrome in rheumatic patients: a systematic review. Eur Rev Med Pharmacol Sci 2012;16:1414–24.
27. Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 2008;47:1686–91.
28. Papo T, Andre MH, Amoura Z, Lortholary O, Tribout B, Guillevin L, et al. The spectrum of reactive hemophagocytic syndrome in systemic lupus erythematosus. J Rheumatol 1999;26:927–30.
29. Kim JM, Kwok SK, Ju JH, Kim HY, Park SH. Reactive hemophagocytic syndrome in adult Korean patients with systemic lupus erythematosus: a case-control study and literature review. J Rheumatol 2012;39:86–93.
30. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003;49:633–9.
31. Arnez MA, de Azevedo MN, Bica BE. Reactive haemophagocytic syndrome in a systemic lupus erythematosus patient: case report. Rev Bras Reumatol 2012;52:790–5.